iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 200.00K | -- | 200.00K | -- | 175.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.00K | -- | 200.00K | -- | 175.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 200.00K | -- | 200.00K | -- | 175.00K |
| SG&A Expenses | 2.17M | 2.97M | 2.74M | 2.80M | 2.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.40M | 4.88M | 4.62M | 4.11M | 3.58M |
| Operating Income | -5.20M | -4.88M | -4.42M | -4.11M | -3.41M |
| Income Before Tax | -5.16M | -4.86M | -4.36M | -3.99M | -3.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.16M | -4.86M | -4.36M | -3.99M | -3.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -4.53M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.16M | -4.86M | -4.36M | -3.99M | -7.78M |
| EBIT | -5.20M | -4.88M | -4.42M | -4.11M | -3.41M |
| EBITDA | -5.00M | -4.69M | -4.22M | -3.91M | -3.19M |
| EPS Basic | -0.36 | -0.49 | -0.48 | -0.46 | -0.91 |
| Normalized Basic EPS | -0.22 | -0.31 | -0.30 | -0.29 | -0.24 |
| EPS Diluted | -0.36 | -0.49 | -0.48 | -0.46 | -0.91 |
| Normalized Diluted EPS | -0.22 | -0.31 | -0.30 | -0.29 | -0.24 |
| Average Basic Shares Outstanding | 14.39M | 9.86M | 9.13M | 8.63M | 8.58M |
| Average Diluted Shares Outstanding | 14.39M | 9.86M | 9.13M | 8.63M | 8.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |